Ecstasy (3,4-methylenedioxymethamphetamine): Cardiovascular effects and mechanisms
- PMID: 33971177
- DOI: 10.1016/j.ejphar.2021.174156
Ecstasy (3,4-methylenedioxymethamphetamine): Cardiovascular effects and mechanisms
Abstract
3,4-methylenedioxymethamphetamine or MDMA (known as "ecstasy") is a recreational drug of abuse, popular worldwide for its distinctive psychotropic effects. Currently, the therapeutic potential of MDMA in psychotherapy has attracted a lot of interest from the scientific community, despite the multitude of effects that this drug of abuse elicits on the human body. While neuronal effects have been the most studied, cardiovascular effects have also been described, as increased blood pressure and heart rate are the most recognizable. However, other effects have also been described at the cardiac (impaired cardiac contractile function, arrhythmias, myocardial necrosis and valvular heart disease) and vascular (vasoconstriction, disruption of vascular integrity and altered haemostasis) levels. Several mechanisms have been proposed, from the interaction with monoamine transporters and receptors to the promotion of oxidative stress or the activation of matrix metalloproteinases (MMPs). This review provides an overview of the cardiovascular implications of MDMA intake and underlying mechanisms, relevant when considering its consumption as drug of abuse but also when considering its therapeutic potential in psychiatry. Moreover, the risk/benefit ratio of the therapeutic use of MDMA remains to be fully elucidated from a cardiovascular standpoint, particularly in patients with underlying cardiovascular disease.
Keywords: 1615); 3,4-Methylenedioxymethamphetamine; Blood pressure; Cardiac effects; Heart rate; MDMA (PubChem CID; Mechanisms; Vascular effects.
Copyright © 2021 Elsevier B.V. All rights reserved.
Similar articles
-
MDMA modulates 5-HT1-mediated contractile response of the human internal thoracic artery in vitro.Toxicol In Vitro. 2019 Mar;55:15-17. doi: 10.1016/j.tiv.2018.11.006. Epub 2018 Nov 15. Toxicol In Vitro. 2019. PMID: 30448555
-
The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder.J Psychoactive Drugs. 2015 Nov-Dec;47(5):337-44. doi: 10.1080/02791072.2015.1094156. Epub 2015 Nov 18. J Psychoactive Drugs. 2015. PMID: 26579955 Review.
-
Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.Br J Pharmacol. 2014 Jan;171(1):83-91. doi: 10.1111/bph.12423. Br J Pharmacol. 2014. PMID: 24328722 Free PMC article.
-
The cardiovascular and cardiac actions of ecstasy and its metabolites.Curr Pharm Biotechnol. 2010 Aug;11(5):470-5. doi: 10.2174/138920110791591526. Curr Pharm Biotechnol. 2010. PMID: 20420571 Review.
-
Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits.J Neurosci. 2001 Nov 1;21(21):8648-54. doi: 10.1523/JNEUROSCI.21-21-08648.2001. J Neurosci. 2001. PMID: 11606652 Free PMC article.
Cited by
-
First-Generation Synthetic Cathinones Produce Arrhythmia in Zebrafish Eleutheroembryos: A New Approach Methodology for New Psychoactive Substances Cardiotoxicity Evaluation.Int J Mol Sci. 2023 Sep 8;24(18):13869. doi: 10.3390/ijms241813869. Int J Mol Sci. 2023. PMID: 37762171 Free PMC article.
-
Key Characteristics and Development of Psychoceuticals: A Review.Int J Mol Sci. 2022 Dec 12;23(24):15777. doi: 10.3390/ijms232415777. Int J Mol Sci. 2022. PMID: 36555419 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
